Global Therapeutic Vaccines Market 2020-2024: Anticipated to Grow by $3.78 Billion, at a CAGR of 43% - ResearchAndMarkets.com

·3-min read

The "Global Therapeutic Vaccines Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.

The global therapeutic vaccines market is poised to grow by $3.78 billion during 2020-2024, progressing at a CAGR of 43% during the forecast period.

This report provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment.

The market is driven by the rising incidence and prevalence of diseases, strong therapeutic vaccine pipeline, and increasing funding for the development of vaccines. The study identifies the increase in R&D activities related to novel therapeutic vaccines as one of the prime reasons driving the therapeutic vaccines market growth during the next few years. Also, initiatives to increase awareness about severe diseases and rise in number of strategic alliances will lead to sizable demand in the market.

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading therapeutic vaccines market vendors that include:

  • Advantagene Inc.

  • Aimmune Therapeutics Inc.

  • Amgen Inc.

  • Gilead Sciences Inc.

  • Immune Response BioPharma Inc.

  • Inovio Pharmaceuticals Inc.

  • Merck & Co. Inc.

  • Novartis AG

  • Sanpower Group Co. Ltd.

  • SOTIO AS

Also, the therapeutic vaccines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

Key Topics Covered

1. Executive Summary

  • Market Overview

2. Market Landscape

  • Market ecosystem

  • Value chain analysis

3. Market Sizing

  • Market definition

  • Market segment analysis

  • Market size 2019

  • Market outlook: Forecast for 2019-2024

4. Five Forces Analysis

  • Five forces summary

  • Bargaining power of buyers

  • Bargaining power of suppliers

  • Threat of new entrants

  • Threat of substitutes

  • Threat of rivalry

  • Market condition

5. Market Segmentation by Type

  • Market segments

  • Comparison by Type

  • Cancer vaccines - Market size and forecast 2019-2024

  • Infectious diseases vaccines - Market size and forecast 2019-2024

  • Neurological diseases vaccines - Market size and forecast 2019-2024

  • Autoimmune diseases vaccines - Market size and forecast 2019-2024

  • Other diseases vaccines - Market size and forecast 2019-2024

  • Market opportunity by Type

6. Customer Landscape

  • Customer landscape

7. Geographic Landscape

  • Geographic segmentation

  • Geographic comparison

  • North America - Market size and forecast 2019-2024

  • Europe - Market size and forecast 2019-2024

  • Asia - Market size and forecast 2019-2024

  • ROW - Market size and forecast 2019-2024

  • Key leading countries

  • Market opportunity by geography

  • Market drivers

  • Market challenges

  • Market trends

8. Vendor Landscape

  • Overview

  • Landscape disruption

9. Vendor Analysis

  • Vendors covered

  • Market positioning of vendors

  • Advantagene Inc.

  • Aimmune Therapeutics Inc.

  • Amgen Inc.

  • Gilead Sciences Inc.

  • Immune Response BioPharma Inc.

  • Inovio Pharmaceuticals Inc.

  • Merck & Co. Inc.

  • Novartis AG

  • Sanpower Group Co. Ltd.

  • SOTIO AS

For more information about this report visit https://www.researchandmarkets.com/r/w6a7hg

View source version on businesswire.com: https://www.businesswire.com/news/home/20200806005657/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Latest stories

  • Trump still faces trouble ahead – whatever the final impeachment result

    Such has been the toxic nature of the current president’s tenure, that calls for action over what has happen on his watch will continue

  • Coronavirus R rate 'could be as low as 0.6' in some parts of England

    The University of Cambridge study estimates the current daily number of new infections occurring across England is 60,200.

  • 'COVID tongue' becoming more common coronavirus symptom

    Leading scientist warns the government needs to expand the list of coronavirus symptoms so people know they're infected.

  • Scottish fishermen forced to sail to Denmark for their catch after Rees-Mogg's 'we’ve got our fish back' boast

    Exports of fresh fish and seafood have been hit by delays following the end of the Brexit transition period.

  • Proud Boxer Dad Looks Over His Adorable Puppies in Indiana

    Three tiny boxer puppies were captured saying hi to their proud papa in Columbus, Indiana, late last year, pawing at the elder dog and wagging their tails.Footage taken by Bailey Noel shows the bigger dog, who Noel told Storyful was their father, inspecting his cute pups. Credit: Bailey Noel via Storyful

  • Exports to EU to plunge by more than one-third because of Boris Johnson’s Brexit trade deal, study warns

    Income per head is forecast to fall by 6 per cent – just 2 per cent less than under a no-deal departure

  • Melania snubs meeting Jill Biden as First Lady-to-be unveils advisors

    Melania Trump is accused of having abdicated any responsibilities associated with her official role

  • Saira Khan says she had to 'tolerate' some 'Loose Women' co-stars

    The 50-year-old left the programme at the beginning of the year.

  • 'Shocking' care home Covid outbreaks at levels not seen since first peak

    Outbreaks of Covid-19 in care homes have more than trebled in a month, with levels of infections now similar to the peak of the first wave, figures show. The latest surveillance data from Public Health England (PHE) reveals that, in the week to January 14, there was the second highest weekly total since records began in April. On Thursday night, senior figures said the numbers were "shocking" and warned: "Care homes cannot be neglected again." It came as the Government closed Britain's borders to Portugal and South America amid fears over a new strain of the virus from Brazil. Ministers had pledged that all care home residents would be vaccinated by the end of this month, but The Telegraph has been told the care home rollout is taking longer than the Government had anticipated. Sources said only 100 residents could be vaccinated in the time it took to administer jabs to 1,000 people in the community. On Thursday night, PHE said more than one third of people aged over 80 in England had been vaccinated, accounting for 56 per cent of the 2,371,407 vaccinations given up to January 10. Matt Hancock, the Health Secretary, has said 25 per cent of older care home residents have received the jab, up from the previous figure of 10 per cent cited by Boris Johnson last week.

  • UK weather: Met Office issues warnings as heavy snow and ice threaten travel disruption

    20cm of snow could fall in hardest-hit areas of Scotland

  • WandaVision opening credits tease arrival of MCU’s most terrifying villain yet

    Pause episode two at the 03:27 mark

  • 'Kind of unbelievable': US Republicans in Britain mull over Trump impact

    'Kind of unbelievable': US Republicans in Britain mull over Trump impactDiaspora of expats voice loyalty, but also withering disgust over Capitol storming – and fatigue

  • Brexit: Boris Johnson ‘in danger of proving he is a buffoon’, says DUP’s Paisley

    PM’s attitude to disruption feels like ‘slap on the face with a wet kipper’, says Brexit backer

  • Trump Jr wanted for questioning by DC attorney general over alleged inaugural funds abuse

    Karl Racine ‘extremely confident’ US president’s eldest son broke law

  • Kate Green calls for Gavin Williamson to resign over free school meals row

    The shadow education secretary said the public has ‘run out of patience’ with Mr Williamson.

  • Travellers from South America banned amid fears over new Covid variant

    Transport Secretary Grant Shapps says it is a ‘precautionary’ measure to ensure the vaccine rollout is not disrupted.

  • Fur-wearing ‘QAnon Shaman’ appeals to Trump personally for pardon over Capitol riots

    ‘My client had heard the oft-repeated words of president Trump’, says lawyer

  • Boris Johnson to hold Downing Street press conference at 5pm as vaccine roll-out gathers pace

    Prime Minister Boris Johnson will hold a Downing Street briefing later this afternoon as the UK continues its battle with the Covid-19 pandemic. Number 10 said the PM will appear alongside England's chief medical officer Professor Chris Whitty and chief scientific officer Sir Patrick Vallance at 5pm. Mr Johnson this week refused to rule out even tougher lockdown restrictions as hospitals come under growing strain from rising Covid-19 cases.

  • North Korea unveils 'world's strongest weapon' at military parade

    Wearing a giant furry hat, black leather jacket and a beaming smile, North Korean leader Kim Jong-un introduced “the world’s strongest weapon” – a new submarine-launched ballistic missile – at a nighttime parade on Thursday in Pyongyang. The display of North Korea’s military might followed a rare congress of the ruling Workers' Party, during which leader Kim denounced the United States as his country's “foremost principal enemy” and vowed to strengthen the North’s nuclear war deterrent. On Friday, the reclusive regime’s state media released 100 photos of a mass celebration of the national armory, including tanks and rocket launchers, all flanked by rows of marching soldiers, noticeably not wearing masks. Military aircraft were illuminated by LED lights as they flew overhead in formation. “They’d like us to notice that they’re getting more proficient with larger solid rocket boosters,” tweeted Ankit Panda, a North Korea expert and author of ‘Kim Jong Un and the Bomb’, as the parade unfolded in Pyongyang’s Kim Il Sung square. As the spectacle reached its climax, the military rolled out what analysts said appeared to be new variants of solid-fuel short-range ballistic missiles – which are more quickly deployed than liquid-fuelled versions - and four Pukguksong-class submarine-launched ballistic missiles (SLBMs).

  • Experts counter charity advice not to drink for two weeks after Covid jab

    Drinking alcohol before or after having the coronavirus vaccine is unlikely to impact the effectiveness of the jab, experts have said. It comes after Drink Aware issued guidance from its independent medical advisory panel warning people not to drink “at least two days before, and at least two weeks after” being vaccinated, “to ensure your immune system is at its best to respond to the vaccine and protect you”. The comments were made by Dr Fiona Sim in her capacity as chair of the advisory panel. She is also a Senior Clinical Adviser at NHS England and a visiting professor at the University of Bedfordshire. The Drink Aware guidance adds there is “little data” about the impact of alcohol on the effectiveness of the Covid-19 vaccine. But Dr Sim states: “Chronic heavy drinking reduces immune protection, and specifically for respiratory infections, which includes Covid-19. “For greatest benefit from the vaccine, it is prudent for you not to drink any alcohol for a few days before, and for at least two weeks after, you've been vaccinated.” But other experts have said this is not necessary and is not recommended in the labelling of the Pfizer or AstraZeneca jabs. “It wouldn’t affect the immune response to be honest,” Dr Gillies O'Bryan-Tear, of the Faculty of Pharmaceutical Medicine, said. “People who drink heavily are somewhat immunosuppressed… (but) it’s certainly not advice around vaccinations I am aware of.” He added that Drink Aware “must have scientific reasons” for issuing the advice, but added: “From my point of view I can’t see why they’ve recommended that”. “We would not deny the vaccination to alcoholics,” he said. “It'll still work, they still need to be protected.” Professor Gary McLean, of the School of Human Sciences at London Metropolitan University and a visiting professor at Imperial College London, said getting “hammered” directly after taking the vaccine wouldn’t be advised. But added “usual drinking within guidelines wouldn't be wouldn't be too negative” on a person’s immune system and is unlikely to impact the effectiveness of the Covid vaccine. It is also not recommended to avoid alcohol days before the seasonal flu jab, he added.